Health Care · Pharmaceutical Preparations · Nasdaq · CIK 1614744 · FYE Dec 31 · Prices AT CLOSE 2026-07-29 (USD) — end-of-day, never a live or intraday quote
Last $1.38Day +0.73%1Y −93.5%Off 52W high −94.3%Vol (1Y) 132.0%
Daily closing price, split-adjusted to the current basis; 3y shown of 1,360 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest0.0% of sh out |
| Days to cover1.0d |
| 13F net flow (QoQ)−0.03% |
| Top-10 13F concentration100.0% |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Earnings (TTM)-$26.4M |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD−79.0% |
| 1Y−93.5% |
| 3Y−99.4% |
| 5Y−99.9% |
| Since incept. (ann.)−71.0% |
Total return through 2026-07-29 · series begins 2021-02-22. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)132.0% |
| Ann. volatility (3Y)138.7% |
| Sharpe (1Y)−1.49 |
| Sharpe (3Y)−0.67 |
| Max drawdown (1Y)−94.2% |
| Max drawdown (3Y)−99.6% |
| Beta (3Y vs SPY)0.22 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 53,403 | $215,748 | 0.00% | −88.6% |
| SmartHarvest Portfolios, LLC | 18,127 | $73,233 | 0.00% | −61.8% |
| BNP PARIBAS FINANCIAL MARKETS | 1,957 | $7,906 | 0.00% | −90.7% |
| RHUMBLINE ADVISERS | 710 | $2,866 | 0.00% | −90.4% |
| SIMPLEX TRADING, LLC | 597 | $2,411 | 0.00% | −93.5% |
| MORGAN STANLEY | 578 | $2,335 | 0.00% | −90.5% |
| GAMMA Investing LLC | 108 | $436 | 0.00% | −96.2% |
| UBS Group AG | 99 | $400 | 0.00% | −96.8% |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
No reported quarters on file for PPBT.
